Systems, methods and devices for treating tinnitus

ABSTRACT

Systems, methods and devices for paired training include timing controls so that training and neural stimulation can be provided simultaneously. Paired trainings may include therapies, rehabilitation and performance enhancement training. Stimulations of nerves such as the vagus nerve that affect subcortical regions such as the nucleus basalis, locus coeruleus or amygdala induce plasticity in the brain, enhancing the effects of a variety of therapies, such as those used to treat tinnitus, stroke, traumatic brain injury and post-traumatic stress disorder.

PRIORITY CLAIM

This application is a continuation application of U.S. Utility patent application Ser. No. 12/485,040, filed Jun. 15, 2009 and claims priority benefits under 35 U.S.C. §119(e) from U.S. Provisional Application No. 61/077,648, filed on Jul. 2, 2008 and entitled “Treatment of Tinnitus with Vagus Nerve Stimulation”; U.S. Provisional Application No. 61/078,954, filed on Jul. 8, 2008 and entitled “Neuroplasticity Enhancement”; U.S. Provisional Application No. 61/086,116, filed on Aug. 4, 2008 and entitled “Tinnitus Treatment Methods and Apparatus”; and U.S. Provisional Application No. 61/149,387, filed on Feb. 3, 2009 and entitled “Healing the Human Brain: The Next Medical Revolution.” The present application incorporates the foregoing disclosures herein by reference.

BACKGROUND

The present disclosure relates generally to therapy, rehabilitation and training including induced plasticity. More particularly, the disclosure relates to methods and systems of enhancing therapy, rehabilitation and training using nerve stimulation paired with training experiences.

SUMMARY

For purposes of summarizing the invention, certain aspects, advantages, and novel features of the invention have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment of the invention. Thus, the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.

BRIEF DESCRIPTION OF THE DRAWINGS

The disclosed inventions will be described with reference to the accompanying drawings, which show important sample embodiments of the invention and which are incorporated in the specification hereof by reference, wherein:

FIG. 1 is a block diagram depicting a paired training system, in accordance with an embodiment;

FIG. 2 is a block diagram depicting a paired training system affecting a subcortical region, in accordance with an embodiment;

FIG. 3 is a block diagram depicting a paired training system affecting the nucleus basalis, in accordance with an embodiment;

FIG. 4 is a block diagram depicting a paired training system affecting the locus coeruleus, in accordance with an embodiment;

FIG. 5 is a block diagram depicting a paired training system affecting the amygdala, in accordance with an embodiment;

FIG. 6 is a block diagram depicting a paired training system affecting the nucleus of the solitary tract (NTS), in accordance with an embodiment;

FIG. 7 is a block diagram depicting a paired training system affecting the cholinergic system, in accordance with an embodiment;

FIG. 8 is a block diagram depicting a paired training system affecting the noradrenergic system, in accordance with an embodiment;

FIG. 9 is a simplified diagram depicting a stimulator, in accordance with an embodiment;

FIG. 10 is a simplified diagram depicting a wireless stimulator, in accordance with an embodiment;

FIG. 11 is a simplified diagram depicting a dual stimulator configuration, in accordance with an embodiment;

FIG. 12 is a simplified diagram depicting a multi-stimulator configuration, in accordance with an embodiment;

FIG. 13 is a graph depicting a constant current stimulation pulse, in accordance with an embodiment;

FIG. 14 is a graph depicting an exponential stimulation pulse, in accordance with an embodiment;

FIG. 15 is a graph depicting a train of constant current stimulation pulses, in accordance with an embodiment;

FIG. 16 is a block diagram depicting a synchronizing control system, in accordance with an embodiment;

FIG. 17 is a graph depicting synchronized pairing, in accordance with an embodiment;

FIG. 18 is a block diagram depicting a response control system, in accordance with an embodiment;

FIG. 19 is a graph depicting response pairing, in accordance with an embodiment;

FIG. 20 is a block diagram depicting a manual control system, in accordance with an embodiment;

FIG. 21 is a graph depicting manual pairing, in accordance with an embodiment;

FIG. 22 is a block diagram depicting a closed loop control system, in accordance with an embodiment;

FIG. 23 is a graph depicting closed loop pairing, in accordance with an embodiment;

FIG. 24 is a block diagram depicting an initiated control system, in accordance with an embodiment;

FIG. 25 is a graph depicting initiated pairing, in accordance with an embodiment;

FIG. 26 is a block diagram depicting a delayed response timing control system, in accordance with an embodiment; and

FIG. 27 is a graph depicting delayed response pairing, in accordance with an embodiment.

FIG. 28 depicts a tinnitus therapy, in accordance with an embodiment; and

FIG. 29 depicts a schematic illustration of the proposed tinnitus pathology and treatment.

DETAILED DESCRIPTION OF THE DRAWINGS

The numerous innovative teachings of the present application will be described with particular reference to presently preferred embodiments (by way of example, and not of limitation). The present application describes several inventions, and none of the statements below should be taken as limiting the claims generally. Where block diagrams have been used to illustrate the invention, it should be recognized that the physical location where described functions are performed are not necessarily represented by the blocks. Part of a function may be performed in one location while another part of the same function is performed at a distinct location. Multiple functions may be performed at the same location.

With reference to FIG. 1, a paired training system is shown. A timing control system 106 is communicably connected to a neural stimulator system 108 and a training system 110. Receiving timing instruction from the timing control system 106, the neural stimulator system 108 provides stimulation to a nerve 104. Similarly receiving timing instruction from the timing control system 106, or providing timing instruction to the timing control system 106, the training system 110 generates desired mental images, ideas, formations, or states in the brain 102. The stimulation of the nerve 104 affects the brain 102 by inducing plasticity. The temporally paired combination of training and stimulation generates manifestations of plasticity in the brain 102 that may be measured by a plasticity measure system 112.

The timing controls system 106 generally provides the simultaneous nature of the pairing. The stimulation and the training are simultaneous in that they occur at the same time, that is, there is at least some overlap in the timing. In some embodiments, the stimulation may lead the start of the training while in other embodiments, the stimulation may follow the start of the training. In many cases, the stimulation is shorter in duration than the training, such that the stimulation occurs near the beginning of the training. Plasticity resulting from stimulation has been shown to last minutes or hours, so a single stimulation pulse may suffice for the whole duration of extended training.

In the treatment of tinnitus, for example, the training may consist of brief audible sounds including selected therapeutic frequencies, paired with stimulations. Because the duration of the sounds may be short, the timing may be controlled very precisely so that the sound coincides temporally with the stimulation. This kind of precision may typically require some form of computer control. In other forms of rehabilitation or education, the timing of the training and/or the stimulation may be controlled manually. Further therapies and training may include training triggered timing or physical condition feedback to provide a closed-loop system. Repeatedly paring vagus nerve stimulation with a single frequency tone can generate plasticity in the primary auditory cortex. Accordingly, exemplary embodiments can include a method including selecting therapeutic sounds based on the measured tinnitus symptoms, wherein each therapeutic sound consists of only one frequency, and wherein the frequency is audible to the patient, and providing a repeated paired training therapy by providing a series of the therapeutic sounds paired with a vagus nerve stimulation pulse train by presenting the vagus nerve stimulation pulse train during presentation of the therapeutic sounds, wherein the vagus nerve stimulation pulse train is generated by a subcutaneous device that provides electrical stimulation of the patient's vagus nerve.

The neural stimulation system 108 may provide stimulation of the nerve 104 using electrical stimulation, chemical stimulation, magnetic stimulation, optical stimulation, mechanical stimulation or any other form of suitable nerve stimulation. In accordance with an embodiment, an electrical stimulation is provided to the left vagus nerve. In an electrical stimulation system, suitable stimulation pulses may include a variety of waveforms, including constant current pulses, constant voltage pulses, exponential pulses or any other appropriate waveform. An electrical stimulation system may use a single stimulation pulse or a train of stimulation pulses to stimulate the nerve 104. Stimulation parameters are selected to affect the brain 102 appropriately, with reference to the affected brain regions or systems, plasticity measures, desynchronization or any other appropriate stimulation parameter measure. A half second train of biphasic stimulation pulses, with a pulse width of 100 microseconds, at 0.8 milliamps and at 30 Hz has been used effectively in the treatment of tinnitus.

Paired stimulation could be accomplished using deep brain stimulation, cortical stimulation, transcranial magnetic stimulation and any other suitable neural stimulation.

One indication of appropriate stimulation may be desynchronization of the cortical EEG. A 0.8 milliamp pulse has been shown to cause cortical desynchronization at frequencies between 30 and 150 Hz. 0.4 milliamp pulses desynchronize the cortex at higher frequencies of 100 to 150 Hz. Desynchronization has been shown to last for at least four seconds in response to stimulation of the vagus nerve.

The simultaneous training system 110 generates the sensory input, motor sequences, cognitive input, mental images, ideas, formations or states that are to be retained by the brain 102. A training system 110 may provide sensory information, such as visual, auditory, olfactory, tactile or any other suitable sensory information. Training system 110 may include physical therapies, cognitive therapies, emotional therapies, chemical therapies, or any other suitable therapies. Training system 110 may present educational information. Training system 110 may include the subject, physically, mentally, emotionally or in any other suitable fashion. Training system 110 may include teachers, doctors, therapists, counselors, instructors, coaches or any other suitable training provider. Training system 110 may evoke specific patterns of neural activity by direct brain stimulation, for example by electrical, magnetic, optical, or any other suitable pattern evocation systems. Training system 110 may inactivate specific brain regions via chemical agents, cooling, magnetic stimulation, or other suitable methods.

The paired training system of FIG. 1 affects the brain 102 to generate plasticity that can be measured by a plasticity measure system 112. In the treatment of tinnitus, a cortical map may be used to measure the map distortion and correction that accompanies the successful treatment of tinnitus. Less invasively, the plasticity can be measured by behaviorally reactions to stimuli, such as a startle test for tinnitus. Further, plasticity can be measured by inquiring about the subjective experience of a subject. If a tinnitus patient no longer experiences a persistent noise, plasticity has been measured.

With reference to FIG. 2, a paired training system affecting a subcortical region 114 of the brain 102, in accordance with an embodiment is shown. The stimulation of nerve 104 affects a subcortical region 114. The subcortical region 114, in turn, affects the brain to induce plasticity. Stimulation of nerves 104 such as the trigeminal nerve and other cranial nerves are known to affect the subcortical region 114.

With reference to FIG. 3, a paired training system affecting the nucleus basalis 116, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the nucleus basalis 116. The nucleus basalis, in turn, affects the brain 102 to induce plasticity.

With reference to FIG. 4, a paired training system affecting the locus coeruleus 118, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the locus coeruleus 118. The locus coeruleus 118, in turn, affects the brain 102 to induce plasticity.

With reference to FIG. 5, a paired training system affecting the amygdala 120, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the amygdala 120. The amygdala 120, in turn, affects the brain 102 to induce plasticity.

With reference to FIG. 6, a paired training system affecting the NTS 122, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the NTS 122. The NTS 122, in turn, affects the brain 102 to induce plasticity.

With reference to FIG. 7, a paired training system affecting the cholergenic system 124, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the cholergenic system 124. The cholergenic system 124 releases acetylcholine (ACh) into the brain 102 inducing plasticity.

With reference to FIG. 8, a paired training system affecting the noradrenergic system 126, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the noradrenergic system 126. The noradrenergic system 126 releases noradrenaline (NE) into the brain 102 inducing plasticity.

With reference to FIG. 9, a neural stimulator system, in accordance with an embodiment, is shown. A neural stimulator control 109 is communicably connected to a neurostimulator 128. Neurostimulator 128 provides a stimulation pulse to a nerve 104 via a pair of electrodes 130 a and 130 b. Electrodes 130 a and 130 b could be cuff electrodes, conductive plates or any other suitable neural stimulation electrode. The neurostimulator 128 may be powered by a piezoelectric powering system as well as near field inductive power transfer, far-field inductive power transfer, battery, rechargeable battery or any other suitable neurostimulator power system. When neural stimulator control 109 receives timing instructions from a timing control system (not shown), the neural stimulator control 109 initiates a stimulation pulse from the neurostimulator 128 via electrodes 130 a and 130 b.

With reference to FIG. 10, a wireless neural stimulator system, in accordance with an embodiment is shown. Neurostimulator 128 communicates with the neural stimulation system 109 using an inductive transponder coil 132. The neural stimulator system 109 includes an external coil 134. Information may be communicated between the neural stimulator system 109 and the neurostimulator 128. Power may be transferred to the neurostimulator 128 by the neural stimulator system.

With reference to FIG. 11, a dual neurostimulator system, in accordance with an embodiment, is shown. Two neurostimulators 128 may stimulate nerve 104. The neurostimulators 128 may be controlled to reinforce each other, as redundancy, or to prevent efferent signals from projecting away from the brain.

With reference to FIG. 12, a multi-neurostimulator system, in accordance with an embodiment, is shown. A plurality of neurostimulators 128 may stimulate nerve 104. The neurostimulators may be controlled to reinforce each other, as redundancy, or to prevent efferent signals from projecting away from the brain.

With reference to FIG. 13, a graph shows a constant current stimulation pulse, in accordance with an embodiment.

With reference to FIG. 14, a graph shows an exponential stimulation pulse, in accordance with an embodiment.

With reference to FIG. 15, a graph shows a train of constant current stimulation pulses, in accordance with an embodiment.

With reference to FIG. 16, a synchronized timing control system, in accordance with an embodiment, is shown. The synchronized timing control system includes a synchronizing timing control 186. The synchronizing timing control 136 is communicably connected to the neural stimulation system 108 and the training system 110. The synchronizing timing control 136 provides timing instructions to the neural stimulation system 108 and the training system 110 so that the stimulation and training occur simultaneously. In the treatment of tinnitus, the stimulation of the nerve may slightly precede each training sound, to give the stimulation time to affect the brain when the training sound is presented. Further embodiments may include other suitable timing variations.

With reference to FIG. 17, a graph shows a possible timing relationship between event and stimulation for a synchronized timing control system.

With reference to FIG. 18, a response timing control system, in accordance with an embodiment, is shown. The response timing control system includes a response timing control 138. The response timing control 138 is communicably connected to the neural stimulation system 108 and a simultaneous event monitor 140. The response timing control 138 receives timing instructions from the event monitor 140 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously. Because the stimulation is generated in response to an event, the stimulation will generally lag the event by some finite time delta t. In cases where there is an event precursor that can be monitored, the timing can be made more exact.

With reference to FIG. 19, a graph shows a possible timing relationship between a monitored event and a nerve stimulation.

With reference to FIG. 20, a manual timing control system, in accordance with an embodiment, is shown. The manual timing control system includes a response timing control 138. The response timing control 138 is communicably connected to the neural stimulation system 108 and a manual input 142. The response timing control 138 receives timing instructions from the manual input 142 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously.

With reference to FIG. 21, a graph shows a possible timing relationship between an event, a manual input and a neural stimulation.

With reference to FIG. 22, a closed loop timing control system, in accordance with an embodiment, is shown. The closed loop timing control system includes a closed loop timing control 144. The closed loop timing control is communicably connected to the neural stimulation system 108 and a sensor 146. The closed loop timing control 144 receives timing instructions from the sensor 146 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously.

With reference to FIG. 23, a graph shows a possible timing relationship between an sensed training event and a neural stimulation is shown.

Sensor 146 may monitor external or internal events, including heart-rate, blood pressure, temperature, chemical levels or any other parameter that may indicate a training event.

With reference to FIG. 24, a initiated timing control system, in accordance with an embodiment, is shown. The initiated timing control system includes an initiated timing control 148. The initiated timing control 148 is communicably connected to a neural stimulation system 106 and an event generator 150. The initiated timing control 148 receives timing information from the neural stimulation system 106, indicating that a nerve has been stimulated. The initiated timing control 148 provides timing instructions to the event generator 150, such as a therapeutic sound generator connected by Bluetooth, such that the event generator 150 generates an event during the stimulation pulse.

With reference to FIG. 25, a graph shows a possible timing relationship between a neural stimulation and an event generation.

With reference to FIG. 26, a delayed response timing control system, in accordance with an embodiment, is shown. The delayed response timing control system includes a delayed response timing control 152. The delayed response timing control 152 is communicably connected to a neural stimulation system 106 and a preliminary event sensor 154. The preliminary event sensor 154 detects a preliminary event that anticipates a pairing event. The delayed response timing control 152 receives timing information from the preliminary event sensor 154, indicating that a preliminary event has been detected. The delay response timing control 152 provides timing instructions to the neural stimulation system 106 to initiate nerve stimulation. In the depicted embodiment, the timing control 152 initiates the stimulation before the beginning of the pairing event, giving a negative delta t. A delay response timing system may initiate stimulation at the same time as the beginning of the pairing event, or after the beginning of the pairing event.

With reference to FIG. 27, a graph shows a possible timing relationship between a neural stimulation, a preliminary event and a pairing event.

Human and animal studies have shown that neurons deprived of auditory input begin to respond to frequencies adjacent to the region of cochlear damage. This plasticity results in a dramatic increase in the number of neurons that respond to the frequencies that order the region of hearing loss. After noise trauma, spontaneous activity in those neurons becomes highly synchronized due to abnormally high input overlaps. This synchronous activity is likely responsible for the subjective tinnitus experience. The severity of tinnitus is highly correlated (r=0.82) with cortical map reorganization caused by hearing loss. In this way, tinnitus is similar to the phantom limb pain after amputation as well as chronic pain syndromes after peripheral nerve damage. The severity of phantom limb pain in amputees is also strongly correlated (r=0.87) with the extent of map reorganization and synchronized spontaneous activity is believed to give rise to ongoing pain. Targeted neural plasticity provides a clear opportunity to restore normal operation to dysfunctional circuits.

VNS may be paired with tones to treat tinnitus. VNS may be paired with touch to treat chronic pain. VNS may be paired with skilled movement to treat motor impairments. VNS may be paired with cognitive therapy to treat cognitive impairments. VNS may be paired with desensitization therapy to treat PTSD or anxiety. VNS may be paired with speech therapy to treat communication disorders.

FIG. 28 depicts a tinnitus therapy, in accordance with an embodiment. A patient has a VNS system implanted so that the vagus nerve electrode contacts a portion of a vagus nerve. The vagus nerve electrode is connected by a flexible wire lead to a pulse generator.

A VNS tinnitus therapy may include a 2.5-hour tinnitus therapy during a single day. During the 2.5 hour tinnitus therapy, a 50 dB tone and paired stimulation train is presented every thirty seconds, effectively presenting the pairs 300 times. Each 50 dB tone and stimulation train lasts for about 0.5 seconds. The stimulation train may be a series of 0.8 mA, 30 Hz stimulation pulses.

FIG. 29 depicts a schematic illustration of the tinnitus pathology and treatment. Cochlear damage at high frequencies results in map reorganization in the auditory cortex, which gives rise to the tinnitus sensation. Pairing VNS with adjacent low tones, the non-tinnitus frequencies, restores the distorted map.

As shown in FIG. 29, under normal conditions each neuron in the auditory cortex is tuned to a small range of tone frequencies (vertical lines) represented on the y-axis. Each line type represents the tone range to which the corresponding part of the auditory cortex responds. This tonotopic mapping of the auditory cortex is shown along the x-axis. The frequency preferences of auditory cortex neurons are ordered to form a topographic map from low to high in the posterior to anterior direction (FIG. 29, left). As shown in the center panel of FIG. 29, when cochlear damage was induced that removed the part of the cochlea that send signals of high frequencies to the auditory cortex, the anterior regions of the auditory cortex began to respond to the middle frequencies from the cochlea. This pathological reorganization of the auditory cortex in response to damage is accompanied by an increase in synchronous activity in the primary auditory cortex.

VNS is paired with low frequency tones to reorganize the auditory cortex as shown in the far right panel of FIG. 29. Note that neurons still do not respond to high frequencies, as those inputs have been destroyed. However, the tonotopic map of the auditory cortex has now been redistributed so that no part of the cortex exhibits the type of pathological plasticity that leads to increased synchronous activity.

The plasticity induced by neural stimulation can be paired with a variety of therapies, rehabilitation, training and other forms of personal improvement. Each therapy acts as a training source. The specific timing requirements associated with each therapy are derived from the specifics of the therapy, such that the stimulation occurs during the training, and most effectively near the beginning of the training. Some possible therapies may include behavioral therapies such as sensory discrimination for sensory deficits, motor training for motor deficits, with or without robotic assistance and cognitive training/rehabilitation for cognitive deficits. Exercise and motor therapy could be paired to treat motor deficits arising from traumatic brain injury, stroke or Alzheimer's disease and movement disorders. Constraint induced therapy could be paired to help prevent the use of alternative strategies in order to force use of impaired methods. Speech therapy could be paired for speech and language deficits. Cognitive therapies could be paired for cognitive problems.

Sensory therapies, such as tones, could be paired to treat sensory ailments such as tinnitus. In treating tinnitus, the paired tones may be at frequencies distinct from the frequencies perceived by the tinnitus patient.

Exposure or extinction therapy could be paired to treat phobias or post-traumatic stress disorder.

Computer-based therapies such as FastForward for dyslexia, Brain Fitness Program Classic or Insight, could be paired to enhance their effects. Psychotherapy could be paired, as well as other therapeutic activities in the treatment of obsessive-compulsive disorder, depression or addiction.

Biofeedback therapy could be paired. For example, temperature readings or galvanic skin responses could be paired to treat anxiety or diabetes. An electromyograph could be paired to improve motor control after brain spinal or nerve damage. A pneumograph could be paired to improve breathing control in a paralyzed patient. A real-time functional magnetic resonance image (fMRI) could be paired to improve pain control or treat obsessive-compulsive disorder (OCD). An electrodermograph, electroencephalograph (EEG), electromyograph (EMG), or electrocardiograph could be paired to treat disorders such as anxiety. An electroencephalograph could be paired to treat epilepsy. A hemoencephalography could be paired to treat migraines. A photoplethysmograph could be paired to treat anxiety. A capnometer could be paired to treat anxiety. Virtual reality therapy could be paired to treat disorders such as addiction, depression, anxiety, or posttraumatic stress disorder. Virtual reality therapy could also be paired to enhance cognitive rehabilitation or performance. Drug therapies could be paired to treat a variety of conditions. Amphetamine-like compounds could be paired to enhance neuromodulators and plasticity. SSRI's could be paired to enhance neuromodulators and plasticity. MOA inhibitors could be paired to enhance neuromodulators and plasticity. Anti-coagulants could be paired to act as clot busters during acute stroke. Various drugs could be paired to stop spasm after nerve or brain damage such as Botulinum toxin, Lidocaine, etc. Small doses of drugs of abuse could be paired to extinguish cravings in addicts.

Hormone therapy could be paired. For example, progesterone, estrogen, stress, growth, or thyroid hormone, etc. could be paired to treat traumatic brain injury or Alzheimer's disease. Glucose therapy could be paired to treat anxiety. Electrical or magnetic stimulation of the central or peripheral nervous system could be paired. For example, transcranial magnetic stimulation could be used to enhance or reduce activity in a specific brain area and thereby focus the directed cortical plasticity. Transcutaneous electrical nerve stimulation could be paired to treat chronic pain, tinnitus and other disorders. Subcutaneous electrical nerve stimulation could be paired to treat chronic pain. Stem cell therapy could be paired to treat disorders such as Parkinson's disease. Gene therapy could be paired to treat conditions such as Down's syndrome, Huntington's disease or fragile X syndrome. Hyperbaric oxygen therapy could be paired to treat carbon monoxide poisoning

Multiple therapies could be paired simultaneously or sequentially.

None of the description in the present application should be read as implying that any particular element, step, or function is an essential element which must be included in the claim scope: THE SCOPE OF PATENTED SUBJECT MATTER IS DEFINED ONLY BY THE ALLOWED CLAIMS. Moreover, none of these claims are intended to invoke paragraph six of 35 USC section 112 unless the exact words “means for” are followed by a participle.

The claims as filed are intended to be as comprehensive as possible, and NO subject matter is intentionally relinquished, dedicated, or abandoned. 

What is claimed is:
 1. A method of treating tinnitus in a patient, comprising: measuring a patient's tinnitus symptoms; selecting therapeutic sounds based on the measured tinnitus symptoms, wherein each therapeutic sound consists of only one frequency, and wherein the frequency is audible to the patient; providing a repeated paired training therapy by providing a series of the therapeutic sounds paired with a vagus nerve stimulation pulse train by presenting the vagus nerve stimulation pulse train during presentation of the therapeutic sounds, wherein the vagus nerve stimulation pulse train is generated by a subcutaneous device that provides electrical stimulation of the patient's vagus nerve; repeatedly presenting the series of paired therapeutic sounds; and reducing the patient's perception of tinnitus.
 2. The method of claim 1, wherein the frequency is outside of one or more tinnitus frequencies characterizing the patient's tinnitus symptoms.
 3. The method of claim 2, wherein the vagus nerve stimulation pulse train lasts 500 milliseconds and comprises 15 pulses 100 microseconds long, and wherein the vagus nerve stimulation occurs at 30 Hertz, has a current amplitude of 0.8 milliamps, and starts 150 milliseconds after the therapeutic sound.
 4. The method of claim 2, wherein the vagus nerve stimulation pulse train starts within 15 seconds of the presentation of the therapeutic tone.
 5. The method of claim 4, wherein the frequency for each paired training therapy is identical.
 6. The method of claim 4, wherein the frequency for each paired training therapy is unique with respect to each other.
 7. The method of claim 1, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 8. The method of claim 1, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 9. The method of claim 1, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 10. The method of claim 1, wherein the paired therapeutic sounds are repeated 300 times.
 11. The method of claim 1, wherein the paired therapeutic sounds are repeated 300 times per day for twenty days.
 12. The method of claim 1, wherein the paired therapeutic sounds are repeated 300 times in 150 minutes.
 13. The method of claim 1, wherein the presentation of paired therapeutic sounds is random.
 14. The method of claim 1, wherein the therapeutic sounds are tones.
 15. The method of claim 1, wherein the paired training therapy generates manifestations of plasticity in a brain of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the generated manifestations of plasticity.
 16. A method of treating tinnitus in a patient, comprising: assessing a patient's tinnitus symptoms; selecting a therapeutic sound based on the assessed tinnitus symptoms, wherein the therapeutic sound consists of only one frequency, and wherein the frequency is audible to the patient; pairing the therapeutic sound with a vagus nerve stimulation pulse train originating from a device that provides electrical stimulation to the vagus nerve by presenting the vagus nerve stimulation pulse train during presentation of the therapeutic sound; repeating the step of selecting a therapeutic sound; repeating the step of pairing the therapeutic sound; and reducing the patient's perception of tinnitus.
 17. The method of claim 16, wherein the frequency is outside of one or more tinnitus frequencies characterizing the patient's tinnitus symptoms.
 18. The method of claim 16, wherein presentation of the therapeutic sound is 500 milliseconds.
 19. The method of claim 16, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 20. The method of claim 16, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 21. The method of claim 16, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 22. The method of claim 16, wherein the paired therapeutic sound is repeated 300 times.
 23. The method of claim 16, wherein the paired therapeutic sound is repeated 300 times per day for twenty days.
 24. The method of claim 16, wherein the paired therapeutic sound is repeated 300 times in 150 minutes.
 25. The method of claim 16, wherein the therapeutic sound is a tone.
 26. The method of claim 16, wherein the device is a subcutaneous device that provides electrical stimulation of the patient's vagus nerve.
 27. The method of claim 16, wherein the paired therapeutic sound with the vagus nerve stimulation pulse train generates manifestations of plasticity in a brain of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the generated manifestations of plasticity.
 28. A method of treating tinnitus in a subject, comprising: assessing a subject's tinnitus symptoms; selecting a plurality of therapeutic sounds based on the assessed tinnitus symptoms, wherein each therapeutic sound consists of only one frequency; repeatedly presenting a plurality of paired therapeutic sounds where one of the therapeutic sounds is paired by presenting a vagus nerve stimulation pulse train during presentation of the one therapeutic sound, wherein the vagus nerve stimulation pulse train is generated by a subcutaneous device that provides electrical stimulation of the subject's vagus nerve; and reducing the subject's perception of tinnitus.
 29. The method of claim 28, wherein presentation of the therapeutic sounds are 500 milliseconds.
 30. The method of claim 28, wherein the frequency is outside of tinnitus frequencies characterizing the subject's tinnitus symptoms, and wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 31. The method of claim 28, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 32. The method of claim 28, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 33. The method of claim 28, wherein the paired therapeutic sounds are repeated 300 times.
 34. The method of claim 28, wherein the paired therapeutic sounds are repeated 300 times per day for twenty days.
 35. The method of claim 28, wherein the paired therapeutic sounds are repeated 300 times in 150 minutes.
 36. The method of claim 28, wherein the presentation of paired therapeutic sounds is random.
 37. The method of claim 28, wherein the therapeutic sounds are tones.
 38. The method of claim 28, wherein the paired therapeutic sound with the vagus nerve stimulation pulse train generates manifestations of plasticity in a brain of the subject, and wherein the reduction of the subject's perception of tinnitus is due to the generated manifestations of plasticity.
 39. A method of treating tinnitus in a subject, comprising: assessing a subject's tinnitus symptoms; selecting a plurality of therapeutic sounds based on the assessed tinnitus symptoms, wherein each therapeutic sound consists of only one frequency; pairing the therapeutic sounds with a plurality of vagus nerve stimulation pulse trains originating from a device that provides electrical stimulation to the vagus nerve by presenting one of the vagus nerve stimulation pulse trains during presentation of one of the therapeutic sounds; repeatedly presenting the paired therapeutic sounds; and reducing the subject's perception of tinnitus.
 40. The method of claim 39, wherein presentation of each therapeutic sound is 500 milliseconds.
 41. The method of claim 39, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 42. The method of claim 39, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 43. The method of claim 39, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 44. The method of claim 39, wherein the paired therapeutic sounds are repeated 300 times.
 45. The method of claim 39, wherein the paired therapeutic sounds are repeated 300 times per day for twenty days.
 46. The method of claim 39, wherein the paired therapeutic sounds are repeated 300 times in 150 minutes.
 47. The method of claim 39, wherein the presentation of paired therapeutic sounds is random.
 48. The method of claim 39, wherein the therapeutic sounds are tones, wherein the device is a subcutaneous device that provides electrical stimulation of the subject's vagus nerve.
 49. The method of claim 39, wherein the paired therapeutic sounds with the vagus nerve stimulation pulse trains results in a plasticity based remapping of an auditory cortex of the subject, and wherein the reduction of the subject's perception of tinnitus is due to the remapping.
 50. A method of treating tinnitus in a patient, comprising: determining a patient's tinnitus symptoms; selecting therapeutic sounds based on the determined tinnitus symptoms, wherein each therapeutic sound consists of only one frequency; pairing a plurality of therapeutic sounds with a plurality of vagus nerve stimulation pulse trains originating from a device that provides electrical stimulation to the vagus nerve by presenting one of the vagus nerve stimulation pulse trains during presentation of one of the therapeutic sounds; repeatedly presenting the plurality of paired therapeutic sounds; and reducing the patient's perception of tinnitus.
 51. The method of claim 50, wherein presentation of each therapeutic sound is 500 milliseconds.
 52. The method of claim 50, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 53. The method of claim 50, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 54. The method of claim 50, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 55. The method of claim 50, wherein the paired therapeutic sounds are repeated 300 times.
 56. The method of claim 50, wherein the paired therapeutic sounds are repeated 300 times per day for twenty days.
 57. The method of claim 50, wherein the paired therapeutic sounds are repeated 300 times in 150 minutes.
 58. The method of claim 50, wherein the presentation of paired therapeutic sounds is random.
 59. The method of claim 50, wherein the therapeutic sounds are tones, wherein the device is a subcutaneous device that provides electrical stimulation of the patient's vagus nerve, wherein each therapeutic sound consists of only one frequency.
 60. The method of claim 50, wherein the paired plurality of therapeutic sounds with the plurality of vagus nerve stimulation pulse trains results in a plasticity based remapping of an auditory cortex of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the remapping.
 61. A method of treating tinnitus in a subject, comprising: determining a subject's tinnitus symptoms; selecting therapeutic sounds based on the determined tinnitus symptoms, wherein each therapeutic sound consists of only one frequency, wherein the frequencies are audible to the subject, and wherein the frequencies are outside of one or more tinnitus frequencies characterizing the subject's tinnitus symptoms; presenting the therapeutic sounds paired with vagus nerve stimulation by presenting a vagus nerve stimulation pulse train during presentation of an individual therapeutic sound, wherein the vagus nerve stimulation pulse train is generated by a subcutaneous device that provides electrical stimulation of the subject's vagus nerve; repeating the presentation of the plurality of paired therapeutic sounds; and reducing the subject's perception of tinnitus.
 62. The method of claim 61, wherein presentation of each therapeutic sound is 500 milliseconds.
 63. The method of claim 61, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 64. The method of claim 61, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 65. The method of claim 61, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 66. The method of claim 61, wherein the paired therapeutic sounds are repeated 300 times.
 67. The method of claim 61, wherein the paired therapeutic sounds are repeated 300 times per day for twenty days.
 68. The method of claim 61, wherein the paired therapeutic sounds are repeated 300 times in 150 minutes.
 69. The method of claim 61, wherein the presentation of paired therapeutic sounds is random.
 70. The method of claim 61, wherein the therapeutic sounds are tones.
 71. The method of claim 61, wherein the presentation of the therapeutic sounds paired with vagus nerve stimulation results in a plasticity based remapping of an auditory cortex of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the remapping.
 72. A method of treating tinnitus in a subject, comprising: assessing a subject's tinnitus symptoms; implementing a tinnitus treatment process on the subject comprising: selecting a therapeutic sound based on the assessed tinnitus symptoms, wherein the selected therapeutic sound consists of only one frequency; pairing the therapeutic sound with a vagus nerve stimulation pulse train originating from a device that provides electrical stimulation to the vagus nerve; repeating the tinnitus treatment process; and reducing the subject's perception of tinnitus.
 73. The method of claim 72, wherein the therapeutic sound comprises a frequency outside tinnitus frequencies characterizing the subject's tinnitus symptoms.
 74. The method of claim 72, wherein presentation of the therapeutic sound is 500 milliseconds.
 75. The method of claim 72, wherein the vagus nerve stimulation generates electroencephalogram (EEG) desynchronization.
 76. The method of claim 72, wherein the vagus nerve stimulation has a current amplitude of 0.8 milliamps.
 77. The method of claim 72, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 78. The method of claim 72, wherein the tinnitus treatment process is repeated 300 times.
 79. The method of claim 72, wherein the tinnitus treatment process is repeated 300 times per day for twenty days.
 80. The method of claim 72, wherein the tinnitus treatment process is repeated 300 times in 150 minutes.
 81. The method of claim 72, wherein the therapeutic sound is a tone.
 82. The method of claim 72, wherein the device is a subcutaneous device that provides electrical stimulation of the subject's vagus nerve.
 83. The method of claim 72, wherein the paired therapeutic sound with the vagus nerve stimulation pulse train results in a plasticity based remapping of an auditory cortex of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the remapping.
 84. A method of treating tinnitus in a patient, comprising: assessing a patient's tinnitus symptoms; implementing a tinnitus treatment process comprising: selecting a sound based on the assessed tinnitus symptoms, wherein the selected sound consists of only one frequency; and presenting the sound to the patient while stimulating the patient's vagus nerve with a device that provides electrical stimulation to the vagus nerve; repeating the tinnitus treatment process; and reducing the patient's perception of tinnitus.
 85. The method of claim 84, wherein the sound selected when implementing the tinnitus treatment process is the same as the sound selected when the tinnitus treatment process is repeated.
 86. The method of claim 84, wherein repeating the tinnitus treatment process comprises implementing the tinnitus treatment processes with each of the therapeutic sounds at least once.
 87. The method of claim 84, wherein repeating the tinnitus treatment process comprises implementing the tinnitus treatment processes at least once for at least two different therapeutic sounds.
 88. The method of claim 84, wherein repeating the tinnitus treatment process comprises implementing the tinnitus treatment processes a plurality of times for at least two different therapeutic sounds.
 89. The method of claim 84, wherein the sound is presented for 500 milliseconds.
 90. The method of claim 84, wherein the vagus nerve is stimulated so that electroencephalogram (EEG) desynchronization is generated.
 91. The method of claim 84, wherein the vagus nerve is stimulated with a current amplitude of 0.8 milliamps.
 92. The method of claim 84, wherein the vagus nerve is stimulated with a vagus nerve stimulation pulse train.
 93. The method of claim 92, wherein the vagus nerve stimulation pulse train has a duration of 500 milliseconds.
 94. The method of claim 84, wherein the tinnitus treatment process is repeated 300 times.
 95. The method of claim 84, wherein the tinnitus treatment process is repeated 300 times per day for twenty days.
 96. The method of claim 84, wherein the tinnitus treatment process is repeated 300 times in 150 minutes.
 97. The method of claim 84, wherein the sound is a tone.
 98. The method of claim 84, wherein the vagus nerve stimulation pulse train is generated by a subcutaneous device that provides electrical stimulation of the patient's vagus nerve.
 99. The method of claim 84, wherein the presentation of the sound to the patient while stimulating the patient's vagus nerve results in a plasticity based remapping of an auditory cortex of the patient, and wherein the reduction of the patient's perception of tinnitus is due to the remapping. 